What Catalysts Could Shift the Narrative for Mondelez as Analyst Views Evolve?

Mondelez International's consensus analyst price target has recently been revised down from $72.71 to $69.61, signaling a shift toward a more cautious outlook on the stock's fair value. This adjustment comes as analysts weigh the company's latest earnings and updated guidance, considering long-term optimism while also recognizing near-term uncertainties. Stay tuned to discover how you can track ongoing shifts in the investment narrative around Mondelez International as market conditions evolve.

Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value Mondelez International.

What Wall Street Has Been Saying

🐂 Bullish Takeaways

Mizuho and Evercore ISI both maintain Outperform ratings, emphasizing confidence in Mondelez’s long-term execution and valuation, even as near-term sales growth moderates. Evercore ISI points to the company’s compelling long-term outlook and the potential for earnings per share growth by 2026, despite current headwinds, revising their price target slightly lower to $72 from $73. JPMorgan reiterates an Overweight stance and sets its revised price target at $74, just a minor reduction, citing the company’s solid organic sales performance and the expectation of only slightly softer results compared to consensus. The firm still sees the fundamentals as attractive in the food sector landscape. Piper Sandler underscores the flexibility of Mondelez to reinvest cost savings, particularly from anticipated cocoa deflation in 2026, back into pricing, advertising and supply chain improvements. This reinvestment could support future growth momentum, though their rating remains Neutral for now. Despite the reduction in price target from $75 to $70, Mizuho keeps its Outperform rating, demonstrating ongoing optimism towards the company’s execution quality and underlying strategy.

🐻 Bearish Takeaways

BofA remains constructive with a Buy rating, but flags the “disappointing” Q3 update and highlights sector-wide risks, noting Mondelez’s lower full-year guidance and revising its price target from $75 to $69. The analyst views this as indicative of broader challenges facing consumer staples, such as demand and earnings pressures into FY25 and FY26. UBS, maintaining a Neutral rating and adjusting its target down to $65 from $69, points to a turbulent earnings season ahead and echoes sector-wide caution among U.S. consumer staples. The firm’s analyst signals concerns about ongoing volatility and the need for improved clarity ahead. Piper Sandler, while projecting some EPS growth potential from cocoa deflation, holds a Neutral rating and tempers expectations for significant upside in earnings growth in the near term. This outlook is reflected in their reduced price target to $63 from $67. Analysts broadly cite valuation and the likelihood that much upside is already reflected in the stock, as well as near-term uncertainties relating to European consumer elasticity and emerging market weaknesses, as critical headwinds to further price appreciation.

Story Continues

Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives or begin writing your own Narrative!NasdaqGS:MDLZ Community Fair Values as at Oct 2025

What's in the News

Mondelez International has partnered with Accenture to deploy a new AI-powered tool designed to cut marketing content production costs by 30% to 50%. This initiative is expected to allow rapid development of short television advertisements, with a potential rollout as early as next year’s holiday season. The company is currently transitioning its products to use natural food dyes. This move responds to shifting consumer preferences and changes in local regulations, although there is no fixed timeline for completing the transition. Jon Halvorson, Mondelez’s global senior vice president of consumer experience, is expected to become the chief marketing officer at Kenvue. This transition concludes his eight-year tenure at Mondelez.

How This Changes the Fair Value For Mondelez International

The consensus analyst price target has fallen from $72.71 to $69.61, reflecting a more conservative outlook on the stock’s fair value. The discount rate remains unchanged at 6.78%. Revenue growth expectations have been lowered slightly, from 4.62% to 4.34% projected annually. The net profit margin has decreased marginally, from 11.04% to 10.81%. This signals revised expectations for profitability. Future P/E ratio projections have dipped from 22.12x to 21.24x, indicating a modest reduction in anticipated earnings multiples.

🔔 Never Miss an Update: Follow The Narrative

Narratives are a smarter way to invest, connecting a company’s story to real financial forecasts and a fair value. On Simply Wall St’s Community page, trusted by millions, Narratives let investors share their perspectives behind the numbers, helping you see the full picture. As new news or earnings roll in, the Narrative updates, showing how fair value and price stack up so you know when it’s time to act.

Read the original Narrative for Mondelez International and keep up with every shift in the story: Mondelez International Narrative

Track how Mondelez’s strategy, such as global pricing and supply chain upgrades, could drive revenue and long-term value. Stay updated as new catalysts and risks are reflected in dynamic fair value estimates, not just historical numbers. Follow the evolving Narrative to see how market news is linked to financial forecasts and valuation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include MDLZ.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments